1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Global Mouth Ulcer Treatment Market 2015-2019

Global Mouth Ulcer Treatment Market 2015-2019

  • September 2015
  • -
  • Infiniti Research Limited
  • -
  • 62 pages

About mouth ulcers
Mouth ulcers are sores that form in the mucous membranes of the oral cavity. They are noncritical and do not pose a health hazard. Mouth ulcers can be caused by oral injury or may arise as a result of underlying disease. They can be associated with intense or moderate pain. The etiology of mouth ulcers include stress, injury, infection, allergy, genetic tendency, and nutritional deficiencies. Treatment involves identification of the cause. The ulcers normally heal by themselves in 10-14 days. Medical treatment is required if the condition persists. Various treatment options, such as antimicrobials, anesthetics, corticosteroids, analgesics, and antihistamines are used to treat them.

Technavio's analysts forecast the global mouth ulcer treatment market to grow at a CAGR of 4.18% over the period 2014-2019.

Covered in this report
The report covers the present scenario and growth prospects of the global mouth ulcer treatment market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various pharmaceutical products used in the treatment of mouth ulcers.

Technavio's report, Global Mouth Ulcer Treatment Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the global mouth ulcer treatment market and its growth prospects in the coming years. The report includes a discussion on the key vendors operating in this market.

Key regions
- Americas
- APAC
- EMEA

Key Vendors
- 3M Healthcare
- Blistex
- Church & Dwight
- Taro Pharmaceuticals
- Valeant Pharmaceuticals

Other prominent vendors
- Blairex Laboratories
- Bristol-Myers Squibb
- Colgate-Palmolive
- Diomed
- Dr.Reddy's
- EPIEN Medical
- Focus Pharmaceuticals
- GlaxoSmithKline
- Henry Schein
- Macoven Pharmaceuticals
- Meda pharmaceuticals
- Novartis
- Pfizer
- Sinclair IS Pharma
- Svizera Labs
- Zila Pharmaceuticals

Market driver
- Increase in prevalence of mouth ulcers
- For a full, detailed list, view our report

Market challenge
- Low diagnosis rates
- For a full, detailed list, view our report

Market trend
- Focus on emerging markets
- For a full, detailed list, view our report


Key Questions Answered in this Report
- What will the market size be in 2019 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

Table Of Contents

Global Mouth Ulcer Treatment Market 2015-2019
PART 01: Executive summary
Highlights
PART 02: Scope of the report
Market overview
Top-vendor offerings
PART 03: Market research methodology
Research methodology
Economic indicators
PART 04: Introduction
Key market highlights
PART 05: Mouth ulcers: Overview
Types of mouth ulcers
Pathophysiology
Causes
Differential diagnosis
Management
Epidemiology
PART 06: Market landscape
Market overview
Market size and forecast
Five forces analysis
PART 07: Market segmentation by formulation
Gel
Spray
Mouthwash
Lozenges
PART 08: Market segmentation by drug class
Antimicrobial
Anesthetic
Corticosteroid
Analgesic
Antihistamine
PART 09: Geographical segmentation
PART 10: Market drivers
PART 11: Impact of drivers
PART 12: Market challenges
PART 13: Impact of drivers and challenges
PART 14: Market trends
PART 15: Vendor landscape
Competitive scenario
Market share analysis 2014
Other prominent vendors
PART 16: Key vendor analysis
3M Company
Blistex
Church and Dwight
Taro Pharmaceuticals
Valeant Pharmaceuticals
PART 17: Appendix
List of abbreviations
PART 18: Explore Technavio

List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Clinical features of different types of ulcers
Exhibit 03: Causes of mouth ulcers
Exhibit 04: Differential diagnosis of mouth ulcers
Exhibit 05: Medication for the management of mouth ulcers
Exhibit 06: Treatment algorithm for mouth ulcers
Exhibit 07: Global mouth ulcer treatment market 2014-2019 ($ billions)
Exhibit 08: Five forces analysis
Exhibit 09: Global mouth ulcer treatment market segment by formulation
Exhibit 10: Global mouth ulcer treatment market segment by drug class
Exhibit 11: Frequently used topical corticosteroids
Exhibit 12: Percentage share of drug classes for mouth ulcer treatment
Exhibit 13: Segmentation of global mouth ulcer treatment market by geography 2014
Exhibit 14: Impact of drivers
Exhibit 15: Impact of drivers and challenges
Exhibit 16: Comparison of aging population in APAC 2010 and 2050 ($ millions)
Exhibit 17: YoY growth and revenue generated from healthcare segment 2011-2014 ($ billions)
Exhibit 18: Share of revenue by different segments 2014
Exhibit 19: YoY growth and revenue generated from personal care products 2012-2014 ($ millions)
Exhibit 20: Share of revenue by different segments 2014
Exhibit 21: Blistex: Product segmentation

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025 Summary Atrial fibrillation (AF) is the most common cardiac arrhythmia and is a heart condition that causes an irregula ...

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025 Summary Venous thromboembolism (VTE) is a disease that includes a myriad of life-threatening disorders ranging from ...

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025 Summary Cardiovascular diseases (CVD), including ischemic heart disease and stroke, are the leading causes of mortality ...

Ulcerative Colitis: Kol Insight

September 2016 $ 8085

Hepatitis C: Kol Insight

September 2016 $ 8085

Download Unlimited Documents from Trusted Public Sources

Therapy Market in Europe

  • November 2016
    19 pages
  • Therapy  

  • Europe  

View report >

Therapy Market and Hypertension Statistics in Asia and the US

  • November 2016
    26 pages
  • Therapy  

    Hypertension  

    Cardiovascular ...  

  • Asia  

    United States  

    Europe  

View report >

Therapy Market in the US - Forecast

  • November 2016
    6 pages
  • Therapy  

    Opioid  

  • United States  

View report >

Related Market Segments :

Therapy
Pharmaceutical

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.